Among women with obesity and unexplained infertility, weight loss before infertility treatment did not increase the likelihood of having a healthy live birth, according to findings published in PLoS Medicine.

WAILEA, Hawaii — In this video perspective from Maui Derm for Dermatologists, George Martin, MD, the meeting’s program director, gives an update on cutaneous oncology treatment options that were discussed during the meeting’s first day.

Ripretinib did not extend PFS compared with sunitinib for patients with advanced gastrointestinal stromal tumor who previously received imatinib, according to randomized phase 3 study results presented during the ASCO Plenary Series.

Substituting a small portion of food with nutrient-dense foods may effectively lower cholesterol among patients with hyperlipidemia without the use of drugs, according to findings published in the Journal of Nutrition.

The FDA approved tebentafusp-tebn for the treatment of adults with HLA-A*02:01-positive unresectable or metastatic uveal melanoma.

In a real-world outpatient population, mineralocorticoid receptor antagonist use in patients with chronic kidney disease was associated with lower rates of renal replacement therapy initiation compared with nonuse, researchers reported.

The virtual 2022 American College of Cardiology Scientific Session will be held from April 2 to 4, and will feature 25 late-breaking clinical trials, 10 featured clinical research presentations and numerous abstract presentations.

Oral immunotherapy has shown promise in inducing remission of specific food allergies, with one FDA-approved option available for peanut allergy, but these patients often shoulder the burden of multiple food allergies.

Removing the race-specific coefficient from the equation that determines eGFR results in a “small but potentially important” effect on the inclusion of patients in [chronic kidney disease] trials, according to published data.

The initial 90‐day window after ACS represents a vulnerable period for recurrent events, possibly attributable to atherothrombosis mechanisms not currently addressed with optimal therapy, researchers reported.